Correction to: Nature Cancer https://doi.org/10.1038/s43018-020-00122-3, published online 2 October 2020.
In the version of this article initially published, there was an error in Table 3. In the row for Oseltamivir, in the fifth column “Antitumor effect in vivo,” the text now reading “Pro-tumorigenic effects in mice: Increased aggressiveness of canine mammary tumor xenografts276” initially appeared as “In canines and mice: Increase mammary tumor aggressiveness276.” The change has been made to the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Derosa, L., Melenotte, C., Griscelli, F. et al. Author Correction: The immuno-oncological challenge of COVID-19. Nat Cancer 3, 371 (2022). https://doi.org/10.1038/s43018-022-00342-9
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s43018-022-00342-9